Michelle Miller

CEO/Managing Director of Biotron Ltd (ASX:BIT)

[Biotron (ASX:BIT) @BiotronLimited]

Biotron Limited’s Managing Director, Dr Michelle Miller, and Sedarex Limited Director, Graeme-David Wald, shared an update on the Sedarex acquisition and introduce its next-generation general anaesthetic technology, SedRx™.

🎥 Watch now: https://t.co/hgUdYlcDwO

[Biotron (ASX:BIT) @BiotronLimited]

Dr Michelle Miller speaks with Mike Loder on Ticker about Biotron’s (ASX: $BIT) acquisition of Sedarex, for a next-gen anaesthetic showing superior safety over propofol and is backed by a $2.5M raise led by @PeakAsset1.
🎥 Watch: https://t.co/YyfRt5jFcr

#Biotech #Sedarex

[Biotron (ASX:BIT) @BiotronLimited]

Biotron Limited MD on webinar today at 12 noon AEDT outlining acquisition and capital raising https://t.co/3MShrSCqZ6

[Biotron (ASX:BIT) @BiotronLimited]

Biotron Limited (ASX:BIT) broadens its pipeline beyond antivirals with acquisition of Sedarex Limited. Opens up clear commercialisation pathway in multi-billion dollar markets @BiotronLimited @PeakAsset1

[Marcus Today @Marcus_Today]

In this ‘On the Couch’ special, @henryj007 sits down with Michelle Miller (@BiotronLimited), Gary Phillips (@Pharmaxis) and Jeremy Curnock Cook (BioScience Managers) to discuss what makes a successful #biotech, and how to invest in #medicalscience.

https://t.co/4HzqZQmBpe

[Biotron (ASX:BIT) @BiotronLimited]

Biotron Limited @BiotronLimited ASX:BIT #ASX presented a webinar today to investors following release of exciting data on #BIT225 against #SARSCoV2 in a #COVID19 model of disease. Watch it now https://t.co/E63BbES7ND

[Biotron (ASX:BIT) @BiotronLimited]

#BiotronLimited presented latest data #CROI2020 showing that #BIT225 promotes innate immune restoration - one step closer to #HIVCure https://t.co/FshEfgnpyv #HIV #ASX #smallcaps

[Biotron (ASX:BIT) @BiotronLimited]

Thinking of those living with HIV and all those no longer with us #WorldAIDSDay We’ve come a long way but not there yet #hivcure

[Small Caps @SmallCapsASX]

Biotron (#ASX: $BIT) rides wave of Phase 2 clinical trial success for HIV drug
https://t.co/2S5UKh0x2D @BiotronLimited #biotech

[Stockhead @StockheadAU]

What should #investors look for in a promising health stock? Here's how to not miss the next @BiotronLimited: https://t.co/tDX5Htt7t6 $BIT #ASX

[Michelle Miller @MillerClarke01]

Great trial outcome for @BiotronLimited #HIVeradication #HIVcure

[Biotron (ASX:BIT) @BiotronLimited]

#ASX:BIT pleased to announce positive results in its Phase 2 Clinical trial of #BIT225 for #HIV https://t.co/JTMCWF8RcO . One step closer to #HIVeradication #HIVcure @BiotronLimited

[Michelle Miller @MillerClarke01]

Great trial outcome for @BiotronLimited #HIVeradication #HIVcure

[Biotron (ASX:BIT) @BiotronLimited]

#AX:BIT @BiotronLimited approach to tackling serious viruses featured in @BioWorld https://t.co/JbAliDtmdN #HIV #virus

[Michelle Miller @MillerClarke01]

Tiny tasting jars of precious Australian native bee honey ready for gifting. What you can do on… https://t.co/VrlG8Kg6zR

[Biotron (ASX:BIT) @BiotronLimited]

Great to see shareholders at yesterday's #BIT @BiotronLimited AGM. Chairman's Address and the CEO Presentation are online at https://t.co/ooG1kng3Kh #ASX #HIV #cure #HBV

[Biotron (ASX:BIT) @BiotronLimited]

Thanks to outgoing @BiotronLimited Director, Prof Denis Wade, for his dedication and contributions to the Company https://t.co/vNr6xnoCDt #ASX #BIT

[Bill Gates @BillGates]

2/ AI, energy, and biosciences are promising fields where you can make a huge impact. It's what I would do if starting out today.

[David Langsam @biotech_daily]

.@BiotronLimited : ‘Nature Article Backs Macrophage Approach’ - subscribe to Biotech Daily https://t.co/4E9331THtC

[Monsoon Communications @MonsoonComms]

@BiotronLimited share progress update on BIT225 Phase 2 HIV-1 clinical trial. #biotech #biotechnews Read More: https://t.co/R1jIl6dWHz

[Biotron (ASX:BIT) @BiotronLimited]

#Biotron brings on second trial site for its Phase 2 #HIV trial with #BIT225 https://t.co/hlgZStrz0e #ASX #biotech #clinicaltrials #HIVcure

[Biotron (ASX:BIT) @BiotronLimited]

China to benefit from faster drug approvals says Shanghai Daily; likely to overtake US as largest pharma market by 2020 #biotron #asx